People · Operator
Named in public records as an officer, director or promoter · active 2011–2021 · Biotechnology, Pharmaceuticals, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biolinq Inc | — | Biotechnology | Series C | $247.4M | $618.5M | 2019 |
| Castle Biosciences Inc | — | Biotechnology | Series A | $59.0M | $361.5M | 2011 |
| Microdermis Corp | — | Pharmaceuticals | Seed | $7.9M | $52.8M | 2015 |
| LiquidGrids, Inc. | — | Other Health Care | Seed | $4.2M | $17.3M | 2014 |
| Amplo Biotechnology, Inc. | — | Biotechnology | Seed | $2.2M | $50.7M | 2021 |
| DiaVacs, Inc. | — | Other | Pre-Seed | $850K | $19.6M | 2015 |
| DelNova, Inc. | — | Other | Pre-Seed | $810K | $18.7M | 2018 |
Daniel Bradbury at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Bradbury on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Garheng Kong | 1 | 16 |
| James Johnson | 1 | 6 |
| JOSEPH C. COOK, JR. | 1 | 5 |
| Matthew Pauls | 1 | 4 |
| Zina Affas Besse | 1 | 4 |
| Alan Lewis | 1 | 4 |
| Terry Vance | 1 | 4 |
| Joseph C. Cook, III | 1 | 4 |
| Nancy Hong | 1 | 4 |
| Christopher Miller | 1 | 4 |
| Bonnie Anderson | 1 | 3 |
| Dan Bradbury | 1 | 3 |
| Mara Aspinall | 1 | 3 |
| CHRIS DIMITROPOULOS | 1 | 3 |
| Lana Ghanem | 1 | 2 |
| RICHARD YANG | 1 | 2 |
| Joe Cook, Jr. | 1 | 2 |
| Derek Maetzold | 1 | 2 |
| Alexander Casdin | 1 | 2 |
| Eddie Shin | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.